The UK biotechnology sector is undergoing significant change as 2024 ends, driven by increased corporate venture capital and private equity funding. This financial boost has spurred activity, with investments in startups and scaling initiatives creating new jobs despite lingering post-COVID challenges.
The Swiss life sciences industry, despite a challenging dip in job vacancies in 2023 (down by 31.4%), shows a robust rebound in 2024, with vacancies projected to rise by 24.1%. R&D roles have been notably active, reflecting global trends and a renewed push in innovation.
Stay informed with the latest insights on labour market shifts, hiring patterns, and industry-specific analytics. Our Snapshots highlight key developments across multiple sectors, helping you navigate the evolving recruitment landscape.
The UK pharmaceuticals sector is recovering from its post-pandemic slowdown, with a focus on addressing the backlog of drug approvals by the MHRA. As approvals accelerate, pharmaceutical manufacturing is ramping up, contributing to an 8.8% increase in engineering vacancies in 2024 compared to last year.
Congratulations to Suzanne Swan and Kirsty Calow who have recently launched Nexa Life Sciences as Managing Partners and part of the Concilium Search Group.
